|
|
| Prisons balk at Sovaldi’s $84,000 cost for hepatitis C treatment |
| By sfgate.com- Stephanie M. Lee and Joe Garofoli |
| Published: 10/21/2014 |
|
In San Francisco’s jails, no inmates with hepatitis C are receiving Sovaldi, the breakthrough pill that can cure most patients in an unprecedented amount of time. In California’s prisons, the drug, made by Gilead Sciences of Foster City, is being given to less than 1 percent of the 17,000 inmates with the virus. Sovaldi could wipe out what has long been an intractable disease. But its $84,000 cost for a 12-week supply doesn’t fit into lean government budgets. Read More. |
MARKETPLACE search vendors | advanced search
IN CASE YOU MISSED IT
|
Comments:
No comments have been posted for this article.
Login to let us know what you think